Abstract
Objectives To test the feasibility, acceptability, and preliminary efficacy of CuidaTEXT: a tailored text message intervention to support Latino dementia family caregivers.
Methods CuidaTEXT is a six-month, bilingual, and bidirectional intervention tailored to caregiver needs (e.g., education, problem-solving, resources). We enrolled 24 Latino caregivers in a one-arm trial, and assessed feasibility, acceptability, and preliminary efficacy within six months.
Results Recruitment took 61 days and enrollment took 20. None of the participants unsubscribed from CuidaTEXT, and 83.3% completed the follow up survey. Most participants (85.7%) reported reading most text messages thoroughly. Participants reported high levels of satisfaction with the intervention (3.6 on a scale from 1 to 4). CuidaTEXT helpfulness was high (3.5-3.8 on a 1 to 4 scale). Compared to baseline, at six months caregiver behavioral symptom distress (0–60) decreased from 19.8 to 12.0, and depression (0-30) from 8.8 to 5.4 (p<0.05).
Conclusions CuidaTEXT demonstrated high levels of feasibility, acceptability, and preliminary efficacy among Latino caregivers.
Clinical implications CuidaTEXT’s feasibility and potential for widespread implementation holds promise in supporting Latino caregivers of people with dementia.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04418232
Funding Statement
This work was supported by Grants R21 AG065755, K01 MD014177, and P30 AG072973 from the NIH.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of the University of Kansas Medical Center gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Author note
Conflict of Interest Disclosures: Each author signed a form for disclosure of potential conflicts of interest. No authors reported any financial or other conflicts of interest in relation to the work described.
Disclosure statement: No potential competing interest was reported by the authors.
Ethical Principles: The authors affirm having followed professional ethical guidelines in preparing this work. These guidelines include obtaining informed consent from human participants, maintaining ethical treatment and respect for the rights of human or animal participants, and ensuring the privacy of participants and their data, such as ensuring that individual participants cannot be identified in reported results or from publicly available original or archival data.
Funding: This work was supported by Grants R21 AG065755, K01 MD014177, and P30 AG072973 from the NIH.
Role of the Funders/Sponsors: None of the funders or sponsors of this research had any role in the design and conduct of the study; collection, management, analysis, and interpretation of data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.
Data availability statement: None
Biographical note: Jaime Perales-Puchalt, PhD, MPH: Dr. Perales-Puchalt is an Assistant Professor at the University of Kansas Alzheimer’s Disease Research Center. His background is in psychology and public health. In addition to conducting research in Spain, England and the United States, Dr. Perales Puchalt has collaborated with teams from other countries in the European Union and the Americas. With a primary focus on reducing Latino dementia disparities, his research has led to the development of a dementia educational/recruitment tool for Latinos. He has also studied the risk of dementia and mild cognitive impairment among sexual and ethnoracial minorities. He currently leads federally funded grants to understand and reduce disparities in dementia care among Latinos. One of those grants includes the first text message caregiver support intervention for Latino family caregivers (CuidaTEXT).
Mariana Ramírez-Mantilla, MSW: Mariana Ramirez is the Director of Juntos; Center for Advancing Latino Health, at the University of Kansas Medical Center. She works leading core administrative functions at Juntos including recruitment, implementation, and evaluation of several research studies. Ms. Ramírez is actively involved in several community boards across the state of Kansas.
Mónica Fracachán-Cabrera, MD: Dr. Fracachán-Cabrera is a Research Assistant at Juntos; Center for Advancing Latino Health, at the University of Kansas Medical Center. She studied and graduated as a surgeon in Venezuela and specialized in Otolaryngology at the Central University of Venezuela. She has worked in several text message interventions among Latinos.
Eric D. Vidoni, PhD: Eric Vidoni, PT, PhD, is Director of the Outreach, Recruitment and Education Core for the University of Kansas Alzheimer’s Disease Research Center and an Associate Professor in the Department of Neurology at the University of Kansas Medical Center. Dr. Vidoni got his Bachelor’s of Science in Kinesiology from the University of Illinois, Urbana-Champaign in 2001. In 2008, he completed his MSPT and PhD as part of a joint curriculum at the University of Kansas. He supports and directs the Kansas Dementia and Aging Research Training Program. As core director, he organizes dementia-focused educational outreach opportunities for healthcare providers and the lay public throughout the region.
Edward F. Ellerbeck, MD: Dr. Ellerbeck is a Professor of Population Health and the Director of the Clinical and Translational Research Education Center at the University of Kansas Medical Center. He has over 25 years of experience in measuring and improving the quality of medical care, particularly in underserved rural and minority communities. His area of interest is in the development of system changes to enhance prevention and treatment of chronic diseases.
A. Susana Ramírez, PhD, MPH: Dr. Ramírez is an Associate Professor of Public Health Communication at the University of California in Merced. As an infodemiologist, Dr. Ramírez applies communication science to advance public health goals for rural and Latino populations.
Amber Watts, PhD: Dr. Watts is an Associate Professor of Clinical Psychology at University of Kansas and Research Fellow of the KU Alzheimer’s Disease Center. Her doctoral degree is in Gerontology and she conducts biopsychosocial research and behavioral interventions on preventable risk factors for cognitive decline and Alzheimer’s disease.
Kristine Williams, RN, PhD, FNP-BC, FGSA, FAAN E: Dr. Williams is a nurse gerontologist and the E. Jean Hill Professor at the University of Kansas School of Nursing. Her research tests interventions designed to improve the quality of life of people with ADRD and their families.
Jeffrey Burns, MD: Dr. Burns is the Director of the KU Alzheimer’s Disease Center and Professor of Neurology. Dr. Burns also runs the center’s Clinical Core. He has been appointed to the Kansas Governor’s Work Group to establish a statewide plan for addressing dementia. Dr. Burns has key expertise in directing dementia care networks and in treating individuals with dementia.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
